Lab urges FDA to suspend ranitidine sales due to degradation risk 13-Jan-2020 By Nick Taylor Emery Pharma files citizen petition arguing data on the degradation of ranitidine supports suspension of the medicine.
Mylan recalls close-to-expiration nizatidine capsules over NDMA impurity 09-Jan-2020 By Ben Hargreaves The recall of products due to NDMA contamination continues, with a new medication, nizatidine, now thought to be affected by the probable carcinogen.